CIK 0001299130
- Accelerated filer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Sign in to watch- Ticker
- PACB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161590339
- Phone
- +1 650-521-8000
- Business address
- 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC, NANOFLUIDICS INC
- 4 Open-market sale President & CEO sold 90,520 shares at $26.91 ($2,435,893)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 37,500 shares at an average $25.89 ($971,058)
- 4 Grant or award Chief Accounting Officer acquired 40,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 234,246 shares at an average $31.02 ($7,265,866)
- 4 Open-market sale Director sold 605,804 shares at an average $34.30 ($20,778,225)
- 4 Open-market sale Director sold 602,448 shares at an average $36.50 ($21,989,724)
- 4 Open-market sale Chief Accounting Officer sold 3,842 shares at $39.20 ($150,606)
- 4 Open-market sale Director sold 220,771 shares at an average $47.99 ($10,595,810)
- 4 Grant or award Chief Accounting Officer acquired 5,050 shares (grant or award)
- 4 Grant or award President & CEO acquired 15,000 shares (grant or award)
Page 8 of 20 · 387 filings